- Home
- OLP vs EYPT Comparison
OLP vs EYPT Comparison
Compare OLP & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- EYPT
- Stock Information
- Founded
- OLP 1982
- EYPT 1987
- Country
- OLP United States
- EYPT United States
- Employees
- OLP N/A
- EYPT N/A
- Industry
- OLP Real Estate Investment Trusts
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- OLP Real Estate
- EYPT Industrials
- Exchange
- OLP Nasdaq
- EYPT Nasdaq
- Market Cap
- OLP 478.2M
- EYPT 967.4M
- IPO Year
- OLP N/A
- EYPT 2005
- Fundamental
- Price
- OLP $20.41
- EYPT $11.02
- Analyst Decision
- OLP
- EYPT Strong Buy
- Analyst Count
- OLP 0
- EYPT 5
- Target Price
- OLP N/A
- EYPT $27.40
- AVG Volume (30 Days)
- OLP 77.0K
- EYPT 1.4M
- Earning Date
- OLP 11-03-2025
- EYPT 11-05-2025
- Dividend Yield
- OLP 8.94%
- EYPT N/A
- EPS Growth
- OLP N/A
- EYPT N/A
- EPS
- OLP 1.29
- EYPT N/A
- Revenue
- OLP $94,839,000.00
- EYPT $51,898,000.00
- Revenue This Year
- OLP $8.83
- EYPT N/A
- Revenue Next Year
- OLP $2.91
- EYPT N/A
- P/E Ratio
- OLP $15.61
- EYPT N/A
- Revenue Growth
- OLP 7.07
- EYPT 2.99
- 52 Week Low
- OLP $19.62
- EYPT $3.91
- 52 Week High
- OLP $30.45
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- OLP 33.08
- EYPT 36.81
- Support Level
- OLP $19.62
- EYPT $11.55
- Resistance Level
- OLP $20.20
- EYPT $13.32
- Average True Range (ATR)
- OLP 0.34
- EYPT 0.82
- MACD
- OLP 0.02
- EYPT -0.06
- Stochastic Oscillator
- OLP 40.88
- EYPT 27.25
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.